Table: Fuji Pharmaceutical -2024/25 group results

Fuji Pharma

11/11/2025 07:30

Nov 11 (Reuters)- 
          Fuji Pharmaceutical  Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Sep 30, 2025    Sep 30, 2024   Sep 30, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           51.68           46.14          57.49        29.03    
               (+12.0 pct)     (+12.8 pct)    (+11.2 pct)  (+20.5 pct) 
  Operating        4.99            3.88           5.52         2.79    
               (+28.6 pct)     (+0.6 pct)     (+10.6 pct)  (+21.0 pct) 
  Recurring        4.46            4.45           5.24         2.66    
               (+0.3 pct)      (-1.6 pct)     (+17.5 pct)  (+20.4 pct) 
  Net
  Net              3.00            6.15           3.81         1.93    
               (-51.2 pct)     (+78.9 pct)    (+27.0 pct)  (+49.9 pct) 
  EPS          122.94 yen      252.85 yen     155.79 yen    78.92 yen  
  Ann Div       45.50 yen       42.50 yen      47.00 yen               
  -Q2 Div       20.00 yen       20.00 yen      21.00 yen               
  -Q4 Div       25.50 yen       22.50 yen      26.00 yen               
  
  NOTE - Fuji Pharmaceutical  Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T